Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
K2M Group Holdings, Inc. to Participate in Four Investor Conferences in March
-
K2M Group Holdings, Inc. to Participate in Four Investor Conferences in March
-
Misonix to Present at the 13th Annual Canaccord Genuity Musculoskeletal Conference on March 6
-
Astronics (ATRO) PT Raised to $50 at Canaccord Genuity; 'Strong backlog offsets margin concerns'
-
Canaccord Genuity Upgrades Itron (ITRI) to Buy
-
Canaccord Genuity Downgrades Badger Meter (BMI) to Sell
-
HMS Holdings (HMSY) PT Raised to $20 at Canaccord Genuity; '2018 guidance based on higher visibility'
-
AtriCure Inc. (ATRC) PT Raised to $26 at Canaccord Genuity
-
Tactile Systems Technology (TCMD) PT Raised to $42 at Canaccord Genuity
-
Livanova (LIVN) PT Raised to $81 at Canaccord Genuity
-
NuVasive (NUVA) PT Lowered to $73 at Canaccord Genuity
-
Tyme Inc. (TYME) Announces 12M Share Common Offering
-
Tyme Technologies Announces Offering of Common Stock
-
Tyme Technologies Announces Offering of Common Stock
-
Hibbett Sports (HIBB) PT Raised to $31 at Canaccord Genuity
-
Vericel to Present at the 13th Annual Canaccord Genuity Musculoskeletal Conference
-
Vericel to Present at the 13th Annual Canaccord Genuity Musculoskeletal Conference
-
Valeant Pharmaceuticals (VRX) PT Raised to $18 at Canaccord Genuity
-
SolarEdge Technologies (SEDG): Raising PT After Non Deal Roadshow - Canaccord
-
Kempharm (KMPH) PT Raised to $11 at Canaccord Genuity
-
Voyager Therapeutics (VYGR) PT Raised to $36 at Canaccord Genuity
-
SolarEdge Technologies (SEDG) PT Raised to $55 at Canaccord Genuity
-
BJ's Restaurants (BJRI) PT Lowered to $45 at Canaccord Genuity
-
Appian Corp. (APPN) PT Raised to $26 at Canaccord Genuity
-
Exact Sciences (EXAS) PT Lowered to $55 at Canaccord Genuity
-
Helios and Matheson (HMNY) Surges on Bullish Initiation from Canaccord
-
Pre-Open Movers 02/22: (BAND) (SAIL) (CAR) Higher; (MIC) (ROKU) (W) Lower (more...)
-
SailPoint Technologies Holdings (SAIL) PT Raised to $17 at Canaccord Genuity
-
Cartiva to Present at 13th Annual Canaccord Genuity Musculoskeletal Conference
-
Biohaven Pharmaceutical Holding (BHVN) PT Raised to $39 at Canaccord Genuity
-
Quantum Materials Corp Announces Review of Strategic Opportunities, Engages Canaccord Genuity as Advisor
-
Quantum Materials Corp Announces Review of Strategic Opportunities, Engages Canaccord Genuity as Advisor
-
Canaccord Genuity Starts Helios and Matheson Analytics (HMNY) at Buy
-
Blueprint Medicines (BPMC) PT Raised to $96 at Canaccord Genuity; 'Catalyst-rich 2018; data flow from all programs'
-
Five9, Inc (FIVN) PT Raised to $31 at Canaccord Genuity
-
Globus Medical (GMED) PT Raised to $53 at Canaccord Genuity
-
LeMaitre Vascular (LMAT) PT Raised to $33 at Canaccord Genuity
-
Pandora (P) PT Lowered to $8 at Canaccord Genuity
-
Everbridge (EVBG) PT Raised to $40 at Canaccord Genuity
-
Bandwidth Inc. (BAND) PT Raised to $30 at Canaccord Genuity
-
Insulet Corporation (PODD) PT Raised to $88 at Canaccord Genuity; 'Q4/17 reinforces our bullish view; plenty to be excited about'
-
Canaccord Genuity Downgrades Fogo de Chao (FOGO) to Hold Following Acquisition
-
Endo International plc (ENDP) PT Lowered to $7 at Canaccord Genuity
-
Quidel Corp. (QDEL) PT Raised to $55 at Canaccord Genuity
-
Fluor (FLR) PT Raised to $64 at Canaccord Genuity
-
Halozyme Therapeutics (HALO) PT Raised to $21 at Canaccord Genuity
-
Canaccord Genuity Downgrades Regeneron Pharma (REGN) to Hold
-
Bitcoin nearly doubles in value from year's low hit in early February
-
OrthoPediatrics Corp. to Participate in Canaccord Genuity’s Musculoskeletal Conference
-
Histogenics Corporation to Present at Upcoming Investor Conferences

